Secondary prevention of anthracycline cardiotoxicity in childhood cancer survivors

被引：0
|
作者：
Leerink, Jan M. [1 ,2 ]
Feijen, Elizabeth A. M. [2 ]
机构：
[1] Univ Amsterdam, Amsterdam Univ Med Ctr, Dept Cardiol, Amsterdam Cardiovasc Sci, NL-1105 AZ Amsterdam, Netherlands
[2] Princess Maxima Med Ctr, Utrecht, Netherlands
来源：
LANCET ONCOLOGY | 2024年 / 25卷 / 02期
关键词：
DYSFUNCTION;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：154 / 156
页数：3
相关论文
共 50 条
  • [31] Ranolazine in the prevention of anthracycline cardiotoxicity
    Corradi, Francesco
    Paolini, Luca
    De Caterina, Raffaele
    PHARMACOLOGICAL RESEARCH, 2014, 79 : 88 - 102
  • [32] Late Cardiotoxicity: Issues for Childhood Cancer Survivors
    Akam-Venkata J.
    Franco V.I.
    Lipshultz S.E.
    Current Treatment Options in Cardiovascular Medicine, 2016, 18 (7)
  • [33] Evaluation of traditional and novel measures of cardiac function to detect anthracycline-induced cardiotoxicity in survivors of childhood cancer
    Dietz, Andrew C.
    Sivanandam, Shanthi
    Konety, Suma
    Kaufman, Christopher L.
    Gage, Ryan M.
    Kelly, Aaron S.
    Neglia, Joseph P.
    Mulrooney, Daniel A.
    JOURNAL OF CANCER SURVIVORSHIP, 2014, 8 (02) : 183 - 189
  • [34] Hypertension Susceptibility Loci are Associated with Anthracycline-related Cardiotoxicity in Long-term Childhood Cancer Survivors
    Hildebrandt, Michelle A. T.
    Reyes, Monica
    Wu, Xifeng
    Pu, Xia
    Thompson, Kara A.
    Ma, Jianzhong
    Landstrom, Andrew P.
    Morrison, Alanna C.
    Ater, Joann L.
    SCIENTIFIC REPORTS, 2017, 7
  • [35] Hypertension Susceptibility Loci are Associated with Anthracycline-related Cardiotoxicity in Long-term Childhood Cancer Survivors
    Michelle A. T. Hildebrandt
    Monica Reyes
    Xifeng Wu
    Xia Pu
    Kara A. Thompson
    Jianzhong Ma
    Andrew P. Landstrom
    Alanna C. Morrison
    Joann L. Ater
    Scientific Reports, 7
  • [36] Evaluation of traditional and novel measures of cardiac function to detect anthracycline-induced cardiotoxicity in survivors of childhood cancer
    Dietz, A. C.
    Sivanandam, S.
    Kaufman, C.
    Kelly, A.
    Neglia, J. P.
    Gaillard, P. R.
    Mulrooney, D. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [37] Evaluation of traditional and novel measures of cardiac function to detect anthracycline-induced cardiotoxicity in survivors of childhood cancer
    Andrew C. Dietz
    Shanthi Sivanandam
    Suma Konety
    Christopher L. Kaufman
    Ryan M. Gage
    Aaron S. Kelly
    Joseph P. Neglia
    Daniel A. Mulrooney
    Journal of Cancer Survivorship, 2014, 8 : 183 - 189
  • [38] Pharmacogenomic screening for anthracycline-induced cardiotoxicity in childhood cancer
    Aminkeng, Folefac
    Ross, Colin J. D.
    Rassekh, Shahrad R.
    Rieder, Michael J.
    Bhavsar, Amit P.
    Sanatani, Shubhayan
    Bernstein, Daniel
    Hayden, Michael R.
    Amstutz, Ursula
    Carleton, Bruce C.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 83 (05) : 1143 - 1145
  • [39] Effectiveness of using cardiac biomarkers to detect late anthracycline cardiotoxicity in childhood leukemia survivors
    Mladosievicova, Beata
    Urbanova, Dagmar
    Radvanska, Eva
    Mikuskova, Eva
    Simkova, Iveta
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [40] Late cardiotoxicity in aging adult survivors of childhood cancer
    Armstrong, Gregory T.
    Ross, Jordan D.
    PROGRESS IN PEDIATRIC CARDIOLOGY, 2014, 36 (1-2) : 19 - 26
12345